- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Received Oxaliplatin-based Chemotherapy
Total 17 results
-
Shanghai Zhongshan HospitalUnknownColorectal Cancer | Gastroesophageal Varices | Received Oxaliplatin-based ChemotherapyChina
-
Shanghai Zhongshan HospitalFirst Affiliated Hospital of Wenzhou Medical University; Anhui Provincial Hospital and other collaboratorsRecruitingGastrointestinal Cancer | Gastroesophageal Varices Hemorrhage | Received Oxaliplatin-based ChemotherapyChina
-
Shanghai Zhongshan HospitalUnknownColorectal Cancer | Gastroesophageal Varices Hemorrhage | Received Oxaliplatin-based ChemotherapyChina
-
University of PennsylvaniaCompletedSubjects Who Have Received Lentiviral-based CART-meso TherapyUnited States
-
Washington University School of MedicineUniversidad de Los AndesNot yet recruitingDecision Making | Mental Health Issue | Empowerment | Refugee Self-reliance | Gender Based Violence Knowledge and Perceived RiskColombia
-
Soonchunhyang University HospitalCompletedEfficacy | Gemcitabine | Advanced Biliary Tract Adenocarcinoma | Oxaliplatin | Combination ChemotherapyKorea, Republic of
-
Chang Gung Memorial HospitalUnknownChemotherapy | Oxaliplatin-induced Peripheral NeuropathyTaiwan
-
Seoul National University Bundang HospitalSeoul National University Hospital; SMG-SNU Boramae Medical Center; Yuhan Pharmaceutical... and other collaboratorsCompletedMetastatic or Recurrent Colorectal Cancer | Refractory to Fluoropyrimidine, Oxaliplatin and Irinotecan | Salvage ChemotherapyKorea, Republic of
-
Eisai Inc.CompletedPatients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LECUnited States
-
Italian Sarcoma GroupCompletedMetastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive | Standard ChemotherapyItaly
-
CHU de ReimsCompletedPatients With Non-small Cell Lung Cancer (NSCLC) and Pleural Mesothelioma and Treated With a Pemetrexed-based ChemotherapyFrance
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPatients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) RiskChina
-
Astellas Pharma IncCompletedNon-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyUnited Kingdom, United States, Brazil, Canada, Germany, Korea, Republic of, Poland, Romania, Russian Federation
-
AstraZenecaISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALITerminatedPatients With Advanced Ovarian Cancer Sensitive to Platinum-based ChemotherapyItaly, Germany
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
Affiliated Hospital to Academy of Military Medical...Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Peking...RecruitingAge Range ≥16 Years, Gender Unlimited | Histopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma | Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed | At Least One Positive Lesion According to the 2014... and other conditionsChina